Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Stromal Tumors

Explore clinical trials studying Gastrointestinal Stromal Tumors. Study availability and eligibility vary by location and protocol.

93 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Stromal Tumors trial results

Completed

Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

NCT03556384

Conditions
Brain Diseases, Cancer, Cardiovascular Diseases, +25 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Miami Miami, Florida, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib

NCT00756509

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Novartis Investigative Site Helsinki, Finland
  • Novartis Investigative Site Lyon, France
  • Novartis Investigative Site Munich, Bavaria, Germany
  • Novartis Investigative Site Bad Saarow, Germany
View Trial Details
Completed

Development of a Multimodal AI System for GIST Management

NCT07454967

Conditions
Artificial Intelligence (AI), Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • The Fifth Affiliated Hospital of Anhui Medical University Fuyang, Anhui, China
  • Baoding Central Hospital Baoding, Hebei, China
  • Cangzhou People's Hospital Cangzhou, Hebei, China
  • Hengshui People's Hospital Hengshui, Hebei, China
View Trial Details
Completed

A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)

NCT04282980

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chinese People's Liberation Army General Hospital Beijing, Beijing Municipality, China
  • Union Medical College Hospital, Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Union Medical College Hospital, Fujian Medical University Fuzhou, Fujian, China
View Trial Details
Completed

CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors

NCT02401815

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Sylvester Comprehensive Cancer Center/ UMHC Miami, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

A Drug-drug Interaction Study of Avapritinib and Midazolam

NCT04908176

Conditions
Astrocytoma, Digestive System Diseases, Digestive System Neoplasms, +21 more
Locations
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions